Maike Frye

2.6k total citations
31 papers, 1.6k citations indexed

About

Maike Frye is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Maike Frye has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Oncology. Recurrent topics in Maike Frye's work include Angiogenesis and VEGF in Cancer (7 papers), Lymphatic System and Diseases (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers). Maike Frye is often cited by papers focused on Angiogenesis and VEGF in Cancer (7 papers), Lymphatic System and Diseases (6 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers). Maike Frye collaborates with scholars based in Germany, Sweden and United States. Maike Frye's co-authors include Dietmar Vestweber, Astrid F. Nottebaum, Alexander Zarbock, Emma Gordon, Lilian Schimmel, Matthias Vockel, Mark Winderlich, Dagmar Zeuschner, Jan Rossaint and Kevin G. Peters and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Maike Frye

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maike Frye Germany 18 809 342 312 287 260 31 1.6k
Mark Winderlich Germany 12 896 1.1× 352 1.0× 354 1.1× 253 0.9× 285 1.1× 25 1.6k
Astrid F. Nottebaum Germany 15 1.1k 1.4× 425 1.2× 219 0.7× 320 1.1× 368 1.4× 23 1.8k
Tiina Henttinen Finland 17 615 0.8× 441 1.3× 293 0.9× 340 1.2× 173 0.7× 23 1.5k
Anika Stadtmann Germany 14 510 0.6× 749 2.2× 203 0.7× 153 0.5× 431 1.7× 16 1.5k
Kati Elima Finland 28 884 1.1× 734 2.1× 538 1.7× 256 0.9× 300 1.2× 53 2.3k
Weiquan Zhu China 20 889 1.1× 248 0.7× 201 0.6× 232 0.8× 71 0.3× 42 2.1k
Sophia K. Khaldoyanidi United States 24 788 1.0× 509 1.5× 389 1.2× 314 1.1× 125 0.5× 50 1.7k
Luis Caveda Italy 13 1.1k 1.3× 324 0.9× 149 0.5× 447 1.6× 371 1.4× 16 1.7k
Martin S. Kluger United States 23 718 0.9× 450 1.3× 234 0.8× 115 0.4× 197 0.8× 27 1.5k
Éva Korpos Germany 19 458 0.6× 341 1.0× 183 0.6× 166 0.6× 170 0.7× 35 1.4k

Countries citing papers authored by Maike Frye

Since Specialization
Citations

This map shows the geographic impact of Maike Frye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maike Frye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maike Frye more than expected).

Fields of papers citing papers by Maike Frye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maike Frye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maike Frye. The network helps show where Maike Frye may publish in the future.

Co-authorship network of co-authors of Maike Frye

This figure shows the co-authorship network connecting the top 25 collaborators of Maike Frye. A scholar is included among the top collaborators of Maike Frye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maike Frye. Maike Frye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nickel, Katrin F., Anne Jämsä, Sandra Konrath, et al.. (2025). Factor XII–driven coagulation traps bacterial infections. The Journal of Experimental Medicine. 222(7). 2 indexed citations
2.
Beerens, Manu, et al.. (2025). Same same but different? How blood and lymphatic vessels induce cell contact inhibition. Biochemical Society Transactions. 53(1). 181–191.
3.
Englert, Hanna, Chandini Rangaswamy, Irm Hermans‐Borgmeyer, et al.. (2025). Sepsis‐induced NET formation requires MYD88 but is independent of GSDMD and PAD4. The FASEB Journal. 39(1). e70301–e70301. 3 indexed citations
4.
Müller, MJ, Hanna Englert, Marguerite Müller, et al.. (2024). A novel stent flow chamber system demonstrates reduced thrombogenicity of bioresorbable magnesium scaffolds. Scientific Reports. 14(1). 26691–26691. 1 indexed citations
5.
Schulte, Christian, Maike Frye, Christoph Waldeyer, et al.. (2023). Antiplatelet drugs do not protect from platelet-leukocyte aggregation in coronary artery disease. Journal of Thrombosis and Haemostasis. 22(2). 553–557. 3 indexed citations
6.
Englert, Hanna, Danika Khong, Nina Wolska, et al.. (2023). Targeting NETs using dual-active DNase1 variants. Frontiers in Immunology. 14. 1181761–1181761. 27 indexed citations
7.
Saygı, Ceren, Silvia Cardarelli, Joanna Kalucka, et al.. (2023). The phosphodiesterase 2A controls lymphatic junctional maturation via cGMP-dependent notch signaling. Developmental Cell. 59(3). 308–325.e11. 3 indexed citations
8.
Konrath, Sandra, Reiner K. Mailer, Manu Beerens, et al.. (2022). Intrinsic coagulation pathway-mediated thrombin generation in mouse whole blood. Frontiers in Cardiovascular Medicine. 9. 1008410–1008410. 9 indexed citations
9.
Masoodi, Mojgan, Manuela Peschka, Stefan Schmiedel, et al.. (2022). Disturbed lipid and amino acid metabolisms in COVID-19 patients. Journal of Molecular Medicine. 100(4). 555–568. 47 indexed citations
10.
Frye, Maike, Timo Frömel, David John, et al.. (2021). EVL regulates VEGF receptor‐2 internalization and signaling in developmental angiogenesis. EMBO Reports. 22(2). e48961–e48961. 16 indexed citations
11.
Frye, Maike, Simon Stritt, Henrik Ortsäter, et al.. (2020). EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity. eLife. 9. 42 indexed citations
12.
Mailer, Reiner K., Marco Heestermans, Michaela Schweizer, et al.. (2020). Xenotropic and polytropic retrovirus receptor 1 regulates procoagulant platelet polyphosphate. Blood. 137(10). 1392–1405. 30 indexed citations
13.
Gordon, Emma, Lilian Schimmel, & Maike Frye. (2020). The Importance of Mechanical Forces for in vitro Endothelial Cell Biology. Frontiers in Physiology. 11. 684–684. 127 indexed citations
14.
Drexler, Hannes C. A., et al.. (2019). Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2*[S]. Molecular & Cellular Proteomics. 18(10). 2058–2077. 22 indexed citations
15.
Frye, Maike, Andrea Taddei, Cathrin Dierkes, et al.. (2018). Matrix stiffness controls lymphatic vessel formation through regulation of a GATA2-dependent transcriptional program. Nature Communications. 9(1). 1511–1511. 125 indexed citations
16.
Martínez‐Corral, Inés, Lukas Stanczuk, Maike Frye, et al.. (2016). Vegfr3-CreER T2 mouse, a new genetic tool for targeting the lymphatic system. Angiogenesis. 19(3). 433–445. 42 indexed citations
17.
Yamamoto, Hiroyuki, Manuel Ehling, Katsuhiro Kato, et al.. (2015). Integrin β1 controls VE-cadherin localization and blood vessel stability. Nature Communications. 6(1). 6429–6429. 168 indexed citations
18.
Wessel, Florian, Mark Winderlich, Maike Frye, et al.. (2014). Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nature Immunology. 15(3). 223–230. 274 indexed citations
19.
Seelige, Ruth, Sigrid März, Jing Ding, et al.. (2013). Cutting Edge: Endothelial-Specific Gene Ablation of CD99L2 Impairs Leukocyte Extravasation In Vivo. The Journal of Immunology. 190(3). 892–896. 27 indexed citations
20.
Pan, Yi, Christian Carbe, Ute Pickhinke, et al.. (2013). Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis. Matrix Biology. 35. 253–265. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026